Lessons Learned From Avastin and OCT–The Great, the Good, the Bad, and the Ugly: The LXXV Edward Jackson Memorial Lecture-Reference-Cited by-同舟云学术

Lessons Learned From Avastin and OCT–The Great, the Good, the Bad, and the Ugly: The LXXV Edward Jackson Memorial Lecture

Published:2019-08 Issue: Volume:204 Page:26-45
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Rosenfeld Philip J.

Funder

Carl Zeiss Meditec

Salah Foundation

National Eye Institute Center Core

Research to Prevent Blindness

Publisher

Elsevier BV

Subject

Ophthalmology

Reference44 articles.

1. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy;Arch Ophthalmol,1999

2. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials- TAP Report 2;Arch Ophthalmol,2001

3. Lessons from recent Phase III trial failures: don't design Phase III trials based on retrospective subgroup analyses from Phase II trials;Rosenfeld;Ophthalmology,2018

4. Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration;Rosenfeld;Ophthalmology,2005

5. Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study;Heier;Ophthalmology,2006

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting treat-and-extend outcomes and treatment intervals in neovascular age-related macular degeneration from retinal optical coherence tomography using artificial intelligence;Frontiers in Medicine;2022-08-09

2. Quantitative assessment of retinal fluid in neovascular age-related macular degeneration under anti-VEGF therapy;Therapeutic Advances in Ophthalmology;2022-01

3. A Proteogenomic Signature of Age-related Macular Degeneration in Blood;2021-07-30

4. Off-Label Use as a Standard of Care;American Journal of Ophthalmology;2021-04

5. Age-related macular degeneration masqueraders: From the obvious to the obscure;Survey of Ophthalmology;2021-03